EHMT2-AS1

Across TCGA pan-cancer cohorts, EHMT2-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated EHMT2-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher EHMT2-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated EHMT2-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

BLCA, THCA, and COAD are the cancer types where EHMT2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.687	0.532	<.001	88	view →
THCA	DFS	Quartile	II,III,IV	0.706	0.912	<.001	86	view →
COAD	OS	Tertile	III,IV	0.313	0.712	.001	71	view →
ACC	DFS	Median	All	0.432	0.725	<.001	59	view →
STAD	DFS	Median	IV	0.185	0.659	.004	47	view →
HNSC	OS	Quartile	III,IV	0.566	0.263	.003	43	view →
DLBC	OS	Tertile	All	0.750	1.000	.002	41	view →
LIHC	DFS	Tertile	II,III,IV	0.284	0.544	.005	39	view →
UCS	OS	Tertile	IV	0.761	0.141	.024	24	view →
PRAD	DFS	Median	All	0.826	0.935	<.001	20	view →
LGG	DFS	Tertile	All	0.737	0.880	.001	12	view →
CESC	DFS	Quartile	All	0.747	0.892	.006	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

EHMT2-AS1–BLCA (OS)

Open the BLCA breakdown →